Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Betamethasone Dipropionate Patent Expiration

Betamethasone Dipropionate is Used for treating plaque psoriasis. It was first introduced by Schering Corp Sub Schering Plough Corp in its drug Diprosone on Approved Prior to Jan 1, 1982. Other drugs containing Betamethasone Dipropionate are Diprolene Af, Diprolene, Betamethasone Dipropionate, Sernivo, Alphatrex. 25 different companies have introduced drugs containing Betamethasone Dipropionate.


Betamethasone Dipropionate Patents

Given below is the list of patents protecting Betamethasone Dipropionate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Sernivo US10179137 Topical formulations comprising a steroid Aug 31, 2030 Primus Pharms
Sernivo US9364485 Topical formulations comprising a steroid Aug 31, 2030 Primus Pharms
Sernivo US9433630 Topical formulations comprising a steroid Aug 31, 2030 Primus Pharms
Sernivo US9439911 Topical formulations comprising a steroid Aug 31, 2030 Primus Pharms
Sernivo US9655907 Topical formulations comprising a steroid Aug 31, 2030 Primus Pharms
Sernivo US9775851 Topical formulations comprising a steroid Aug 31, 2030 Primus Pharms
Sernivo US9877974 Topical formulations comprising a steroid Aug 31, 2030 Primus Pharms



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Betamethasone Dipropionate's patents.

Given below is the list recent legal activities going on the following patents of Betamethasone Dipropionate.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 8th Yr, Small Entity 06 Mar, 2024 US9433630
Payment of Maintenance Fee, 8th Yr, Small Entity 14 Dec, 2023 US9364485
Payment of Maintenance Fee, 4th Yr, Small Entity 15 Jul, 2022 US10179137
Payment of Maintenance Fee, 4th Yr, Small Entity 30 Jul, 2021 US9877974
Email Notification
Critical
 26 Apr, 2021 US10179137
Change in Power of Attorney (May Include Associate POA)
Critical
 26 Apr, 2021 US10179137
Correspondence Address Change
Critical
 22 Apr, 2021 US10179137
Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 22 Apr, 2021 US10179137
Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 21 Apr, 2021 US9877974
Change in Power of Attorney (May Include Associate POA)
Critical
 21 Apr, 2021 US9877974


Betamethasone Dipropionate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Betamethasone Dipropionate Generic API Manufacturers

Several generic applications have been filed for Betamethasone Dipropionate. The first generic version for Betamethasone Dipropionate was by Actavis Mid Atlantic Llc and was approved on Jul 31, 1985. And the latest generic version is by Aurobindo Pharma Ltd and was approved on Apr 10, 2024.

Given below is the list of companies who have filed for Betamethasone Dipropionate generic, along with the locations of their manufacturing plants worldwide.


1. ACTAVIS MID ATLANTIC

Actavis Mid Atlantic Llc has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Actavis Mid Atlantic.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.05% BASE

ointment, augmented Prescription TOPICAL AB Aug 31, 1995





2. ALPHARMA US PHARMS

Alpharma Us Pharmaceuticals Division has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Alpharma Us Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.05% BASE

lotion Discontinued TOPICAL N/A Feb 3, 1987





3. ANDA REPOSITORY

Anda Repository Llc has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Anda Repository.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.05% BASE

cream, augmented Discontinued TOPICAL N/A Jan 23, 2004





4. AUROBINDO PHARMA LTD

Aurobindo Pharma Ltd has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.05% BASE

ointment, augmented Prescription TOPICAL AB Apr 10, 2024


Manufacturing Plant Locations
New

Aurobindo Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma Ltd as present at those locations.

Country City Firm Name
India
Medchal Aurobindo Pharma Ltd





5. COSETTE

Cosette Pharmaceuticals Inc has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Cosette.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.05% BASE

cream Prescription TOPICAL AB Oct 12, 2018


Manufacturing Plant Locations
New

Cosette's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Cosette as present at those locations.

Country City Firm Name
United States
South Plainfield Cosette Pharmaceuticals, Inc.
Lincolnton Cosette Pharmaceuticals NC Laboratories, LLC





6. ENCUBE

Encube Ethicals Private Ltd has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Encube.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.05% BASE

lotion, augmented Discontinued TOPICAL N/A Feb 13, 2018


Manufacturing Plant Locations
New

Encube's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Encube as present at those locations.

Country City Firm Name
India
Ponda Encube Ethicals Pvt. Ltd.
Andheri East, Mumbai Encube Ethicals Private Ltd





7. FOUGERA PHARMS

Fougera Pharmaceuticals Inc has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Fougera Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.05% BASE

lotion, augmented Prescription TOPICAL AB May 21, 2007





8. FOUGERA PHARMS INC

Fougera Pharmaceuticals Inc has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Fougera Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.05% BASE

(reference standard)

lotion Prescription TOPICAL AB Aug 12, 1985





9. GLENMARK PHARMS INC

Glenmark Pharmaceuticals Inc Usa has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.05% BASE

(reference standard)

cream, augmented Prescription TOPICAL AB Sep 23, 2008





10. HIKMA

Hikma Pharmaceuticals Usa Inc has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Hikma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.05% BASE

lotion, augmented Discontinued TOPICAL N/A Oct 11, 2019


Manufacturing Plant Locations
New

Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.

Country City Firm Name
United States
Eatontown Hikma Pharmaceuticals USA, Inc.
Cherry Hill Hikma Pharmaceuticals USA Inc.
Carlsbad Hikma Cali Inc. DBA Leucadia Pharmaceuticals
Dayton Hikma Injectables USA Inc
Portugal
Terrugem Snt Hikma Farmaceutica, (Portugal) S.A.
Jordan
Amman Hikma Pharmaceuticals LLC





11. LUPIN LTD

Lupin Ltd has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Lupin Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.05% BASE

ointment, augmented Prescription TOPICAL AB Dec 18, 2019


Manufacturing Plant Locations
New

Lupin Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Lupin Ltd as present at those locations.

Country City Firm Name
India
Aurangabad Lupin Ltd.





12. PADAGIS ISRAEL

Padagis Israel Pharmaceuticals Ltd has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Padagis Israel.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.05% BASE

ointment Prescription TOPICAL AB Apr 12, 2022


Manufacturing Plant Locations
New

Padagis Israel's manufacturing plants are situated in 1 country - Israel. Given below are the details of these plant locations as well as the firm names of Padagis Israel as present at those locations.

Country City Firm Name
Israel
Yerucham Padagis Israel Pharmaceuticals Ltd.





13. PADAGIS US

Padagis Us Llc has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Padagis Us.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.05% BASE

ointment, augmented Discontinued TOPICAL N/A Nov 9, 2017


Manufacturing Plant Locations
New

Padagis Us's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Padagis Us as present at those locations.

Country City Firm Name
United States
Minneapolis Padagis US LLC





14. PERRIGO NEW YORK

Perrigo New York Inc has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Perrigo New York.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.05% BASE

cream Discontinued TOPICAL N/A Nov 26, 1997


Manufacturing Plant Locations
New

Perrigo New York's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Perrigo New York as present at those locations.

Country City Firm Name
United States
Bronx Perrigo New York, Inc.





15. SAVAGE LABS

Savage Laboratories Inc Div Altana Inc has filed for 1 generic for Betamethasone Dipropionate. This eq 0.05% base version comes by the name ALPHATREX. Given below are the details of the strengths of this generic introduced by Savage Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.05% BASE

lotion Discontinued TOPICAL N/A Aug 12, 1985





16. SHREE HARI INTL

Shree Hari International Llc has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Shree Hari Intl.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.05% BASE

lotion Discontinued TOPICAL N/A Aug 12, 1985





17. TARO

Taro Pharmaceuticals Inc has filed for 2 different strengths of generic version for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Taro.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.05% BASE

(reference standard)

lotion, augmented Prescription TOPICAL AB May 21, 2007
EQ 0.05% BASE/SPRAY

spray Discontinued TOPICAL N/A Jun 17, 2020


Manufacturing Plant Locations
New

Taro's manufacturing plants are situated in 3 countries - United States, Israel, Canada. Given below are the details of these plant locations as well as the firm names of Taro as present at those locations.

Country City Firm Name
United States
Honolulu Taro Delight, LLC
Hawthorne Taro Pharmaceuticals U.S.A., Inc.
Israel
Haifa Taro Pharmaceutical Industries, Ltd.
Canada
Brampton Taro Pharmaceuticals Inc.





18. TASMAN PHARMA

Tasman Pharma Inc has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Tasman Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.05% BASE

ointment Prescription TOPICAL AB Feb 18, 2022





19. TEVA

Teva Pharmaceuticals Usa Inc has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Teva.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.05% BASE

cream Discontinued TOPICAL N/A Aug 10, 1987


Manufacturing Plant Locations
New

Teva's manufacturing plants are situated in 6 countries - United States, India, Canada, Czech Republic, Ireland, Israel. Given below are the details of these plant locations as well as the firm names of Teva as present at those locations.

Country City Firm Name
United States
Fort Dodge TEVA Animal Health Inc
Horsham Teva Branded Pharmaceutical Products R&D
Malvern Teva Branded Pharmaceutical Products R&D, Inc.
Miami Teva Branded Pharmaceutical Products R & D, Inc.
India
Gajraula, Amroha Teva API India Private Ltd.
Bhind Teva API India Ltd- Malanpur
Canada
Stouffville Teva Canada Limited
Markham Teva Canada Limited
Scarborough Teva Canada Limited
Czech Republic
Opava Teva Czech Industries s.r.o.
Ireland
Dundalk Teva Laboratories Ireland Ltd
Israel
Kiryat-Shmona TEVA Medical Ltd.





20. ZYDUS LIFESCIENCES

Zydus Lifesciences Ltd has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Zydus Lifesciences.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.05% BASE

ointment Prescription TOPICAL AB Jul 14, 2020


Manufacturing Plant Locations
New

Zydus Lifesciences's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Zydus Lifesciences as present at those locations.

Country City Firm Name
India
Ahmedabad ZYDUS LIFESCIENCES LIMITED
Ankleshwar Zydus Lifesciences Limited
Ahmedabad Zydus Lifesciences Limited
Jarod Zydus Lifesciences Limited
District Solan Zydus Lifesciences Limited
Thane Zydus Lifesciences Limited
Matoda Zydus Lifesciences Limited
Moraiya, Ahmedabad Zydus Lifesciences Limited
Dabhasa Zydus Lifesciences Limited





21. ZYDUS PHARMS

Zydus Pharmaceuticals Usa Inc has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Zydus Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.05% BASE

cream Prescription TOPICAL AB Jan 11, 2019